Skip to main content
Equibles

Long Focus Capital Management, LLC

Position in BNTX — BioNTech SE

CIK 1602716 SAN JUAN, PR
Back to BNTX Full portfolio

Position in BNTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$58,063,200
+$2,602,080 QoQ
Shares Held
624,000
0.0% QoQ
Ownership
0.248%
of shares outstanding
% of Portfolio
2.39%
of 13F equity value
Holder Rank
#15
of 283 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BNTX Over Time

Shares Held

Position Value (USD)

Derivatives in BNTX

reported options exposure · as of Dec 31, 2024
CallValue
$103,694,500
CallShares
910,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Long Focus Capital Management, LLC holds $196,301,316 across 7 Biotechnology names. BNTX ranks #1 (29.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BNTX
BioNTech SE
This page 		624,000 $58,063,200
2 INSM
INSMED Inc
 528,000 $56,295,360
3 AURA
Aura Biosciences, Inc.
 5,119,582 $36,349,032
4 MGTX
MeiraGTx Holdings plc
 1,080,300 $14,594,853
5 BCYC
Bicycle Therapeutics PLC
 3,310,687 $14,037,312
6 IOVA
Iovance Biotherapeutics, Inc.
 2,100,000 $8,736,000
7 CLLS
Cellectis S.A.
 2,741,853 $8,225,559

All Filings in BNTX

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $58,063,200 624,000
2026-03-31 $55,461,120 624,000
2025-12-31 $48,328,756 507,655
2025-09-30 $39,216,736 397,655
2025-06-30 $22,135,432 207,903
2025-03-31 $14,478,540 159,000
2024-12-31 $103,694,500 910,000